Neurotechnology startup Mave Health has raised $2.1 million (around ₹18 crore) in a seed funding round led by Blume Ventures, with participation from multiple global investors.
The funding will support the launch of its innovative brain stimulation wearable headset in India and the United States.
Funding Details
The seed round saw participation from:
- Blume Ventures (Lead Investor)
- Inuka Capital
- Stanford Angels
- Founders of Groww
- Raymond Russell
- Aureolis Ventures
- Juhi Bhatnagar
- All In Capital (existing investor)
This follows the company’s earlier $750K pre-seed round in November 2023.
How the Funds Will Be Used
Mave Health plans to deploy the fresh capital to:
- Launch its wearable device in India and the US
- Scale manufacturing capabilities
- Expand product development and distribution
This marks a major step toward entering the global neurotechnology market.
About Mave Health
Founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, Mave Health is building non-invasive neurotechnology solutions to improve mental performance.
The startup focuses on enhancing:
- Focus
- Mood
- Stress regulation
through wearable brain stimulation technology.
The Product: Brain Stimulation Wearable
Mave Health’s flagship product is a lightweight wearable headset (~100g) designed for daily use.
Key Features:
- Uses tDCS (transcranial direct current stimulation)
- Targets the prefrontal cortex
- Requires only 20 minutes daily usage
- Works during everyday activities
- Battery lasts up to 1 month per charge
The device delivers low-intensity electrical stimulation to improve attention and emotional balance.
Companion App and User Experience
The headset is supported by a mobile app that allows users to:
- Track sessions
- Personalize usage protocols
- Monitor progress
Importantly, the app does not collect sensitive brain data, ensuring user privacy.
Users typically start noticing improvements within 15–20 days, with benefits increasing over time.
Strong Early Market Traction
Mave Health has already seen strong early demand.
Key Highlights:
- 3 product batches sold out within 36 hours
- 1 million+ impressions on launch video
- Interest from global tech leaders and athletes
- Backed by 500+ beta users before launch
The product is currently available for pre-order in India and the US, with shipments starting in April 2026.
User Impact and Results
Based on early user data (4-week usage):
- 80% users reported 60%+ productivity improvement
- 75% users saw 50%+ stress reduction
- Average mood improvement: 77%
These results highlight the potential of wearable neurotechnology in improving mental performance.
Growing Neurotechnology Market
The global neurotech and mental wellness market is expanding rapidly due to:
- Increased focus on mental health
- Demand for non-invasive solutions
- Rise of wearable health devices
Startups like Mave Health are combining AI, neuroscience, and hardware innovation to create next-generation wellness products.
Conclusion
With its $2.1 million funding, Mave Health is positioning itself as a key player in the emerging neurotechnology space.
By launching a consumer-friendly brain stimulation device, the company aims to redefine how people improve focus, reduce stress, and enhance mental performance in daily life.
